Study of Administration of Intravenous Naglazyme Following Allogeneic Transplantation for Maroteaux-Lamy Syndrome
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Galsulfase (Primary)
- Indications Mucopolysaccharidosis VI
- Focus Therapeutic Use
- 07 Aug 2017 Planned End Date changed from 1 Mar 2020 to 1 Jul 2018.
- 07 Aug 2017 Planned primary completion date changed from 1 Mar 2020 to 1 Jul 2018.
- 07 Aug 2017 Status changed from recruiting to active, no longer recruiting.